Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Total revenues	$ 188,063	$ 147,593
Cost of revenues	(92,213)	(122,360)
Gross profit	95,850	25,233
Operating expenses:
Research and development	1,746,768	1,309,522
General and administrative	2,551,710	949,318
Total operating expenses	4,298,478	2,258,840
Loss from operations	(4,202,628)	(2,233,607)
Other expense:
Foreign currency transaction (loss)/gain	(108,293)	27,253
Interest expense, net	(201,472)	(213,505)
Research and development incentives	163,372	57,381
Total other expense	(146,393)	(128,871)
Net loss applicable to common stockholders	$ (4,349,021)	$ (2,362,478)
Basic net loss per share (in Dollars per share)	$ (0.10)	$ (0.06)
Diluted net loss per share (in Dollars per share)	$ (0.10)	$ (0.06)
Basic weighted average common shares outstanding (in Shares)	42,920,040	36,818,154
Diluted weighted average common shares outstanding (in Shares)	42,920,040	36,818,154
Contract revenue
Total revenues	$ 50,000	$ 33,351
Grant revenue
Total revenues	$ 138,063	$ 114,242